Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

aubex pharma pty ltd - doxylamine succinate, quantity: 25 mg - tablet, uncoated - excipient ingredients: pregelatinised starch; lactose monohydrate; microcrystalline cellulose; purified water; magnesium stearate - temporary relief of sleeplessness.

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - doxylamine succinate, quantity: 25 mg - tablet, uncoated - excipient ingredients: croscarmellose sodium; magnesium stearate; microcrystalline cellulose; povidone - temporary relief of sleeplessness.

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - doxylamine succinate, quantity: 25 mg - tablet, uncoated - excipient ingredients: croscarmellose sodium; magnesium stearate; microcrystalline cellulose; povidone - temporary relief of sleeplessness.

Сједињене Америчке Државе - Енглески - NLM (National Library of Medicine)

bryant ranch prepack - doxylamine succinate (unii: v9bi9b5yi2) (doxylamine - unii:95qb77jkpl), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z) - doxylamine succinate and pyridoxine hydrochloride delayed-release tablets are indicated for the treatment of nausea and vomiting of pregnancy in women who do not respond to conservative management.   limitations of use doxylamine succinate and pyridoxine hydrochloride delayed-release tablet has not been studied in women with hyperemesis gravidarum.   doxylamine succinate and pyridoxine hydrochloride is contraindicated in women with any of the following conditions:   - known hypersensitivity to doxylamine succinate, other ethanolamine derivative antihistamines, pyridoxine hydrochloride or any inactive ingredient in the formulation monoamine oxidase (mao) inhibitors intensify and prolong the adverse central nervous system effects of doxylamine succinate and pyridoxine hydrochloride [see drug interactions (7.1)].  risk summary doxylamine succinate and pyridoxine hydrochloride is intended for the treatment of nausea and vomiting of pregnancy in women who do not respond to conservative management. maternal risks a

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

symbion pty ltd - doxylamine succinate -

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

pharmacare laboratories pty ltd - doxylamine succinate -

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

pharmacare laboratories pty ltd - doxylamine succinate -

Аустралија - Енглески - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - doxylamine succinate -

Канада - Енглески - Health Canada

paladin labs inc. - doxylamine succinate - tablet - 25mg - doxylamine succinate 25mg - ethanolamine derivatives

Ирска - Енглески - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited t/a sanofi - paracetamol; codeine phosphate hemihydrate; doxylamine succinate; caffeine - film-coated tablet - 450mg/10mg/5mg/30 milligram(s) - opioids in combination with non-opioid analgesics; codeine and paracetamol